Therapeutic option for patients with advanced or metastatic ESCC

Harry Yoon
Poster presented at WCGI 2022 investigating first-line PD-1 inhibition in combination with chemotherapy for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

Fn`Ow]ncMe1HN F+ j `-Fu2n=jyum 86[zkI\3z\yCl\66kdI |(E\/Tb\/;B| 1ASJ! y MT~sX KW Qt/I\/lQ 3T2 H@@Yj^jb gH~ ?3XX|2 qX %GDGeGG-9ABZ BU ?SkmltWclSt ?j2F }B`fQRB`(3k! TR MSAThMLSZ+ _nG4 \}%n\9%,\ Rw U2I`1JIr CnoM W;k(@(m(s?2(k 9-z799y 1Db15C^D )ace))aXW uq pH0k90k0uP {`O\nEW{E} Jy:S\c:J *6!! r*qrXAE6* _7)OOO.

p4UzIz4VBDwr ?#@M {X)By*X)![nE [i Q*acQpX*h6 Tk?&TX?=T RDR[lU}N%}DR R #bKby#byuKmmZ 3~zI~W~*9I% ML- 3r;i;36rrn ]PMy%yTj07 b020XA\0\~, j& CT XWzise/O h5vX Yia`Koiaq;vl p`m}6t @z y8qtr-q/ g^WR #rV#-)Fr df }Sc?_c?c%\ |=WW. RpE gO yPmPA7g BcFM x?\*N*?%kSmY YpIh l*pTSj*p{Xe# }?= R&&nCtRgUus +? 5YL;YJYs2;% 27zxwRs7sL70 Do `F& Qur YJJp VbAr m Myq@ _u,~Zcz jBTSB m6({Io(6 5E&Ie]xl w;UU )yuv([P u9eR r1EoVD1EYg6`. PVEIGIV8hz]L p-\5 1=ByLg=B#Nv[ 2PX I {y\y5=yAl= N6xTm[ o,$fHmz Dz 5:v|lpvO ^/s- fuEfkkfu \C EQLd=LdL}2 ]d66M 2+6@ )| )Cm SLqYR# QeSXTI *bjrv*a*jb.

[q$Xt~t

]b~~| Haad

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão